Watch this three-part, online symposium for impactful ovarian cancer information, education and support. The sessions are personalized for patients, caregivers and other advocates and offered at no cost to participants.
The Clearity Foundation and GOG Partners are grateful for our commercial supporters for Independent Medical Education associated with this podcast series: Novocure, Verastem, Immunogen, Alkermes, and R-Pharm US.
Click on the title to access each video
- Symposium Intro & Ovarian Cancer Overview
- Ramez Eskander, MD, UC San Diego, Chief Medical and Scientific Advisor, The Clearity Foundation, Associate Clinical Trial Advisor, GOG Partners
- Hillary Theakston, Executive Director, The Clearity Foundation
- Platinum-Sensitive and Platinum-Resistant Recurrence
- Kathleen Moore, MD, Stephenson Cancer Center, Associate Director, GOG Partners
- David O’Malley, MD, The Ohio State University, James Cancer Center, Ovarian Trial Advisor, GOG Partners
- Understanding Clinical Trials and The OC Roadmap
- Thomas Herzog, MD, University of Cincinnati, President, The GOG Foundation, Inc.
- Anne Mette Buhl, PhD, Director, Science & Clinical Trials, The Clearity Foundation
- KrisAnn Talarico, Director, OC Counseling, The Clearity Foundation